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excluded. Cox proportional hazard models were built to predict
the time dependent likelihood of no recurrence, as a function of
drug persistence, for patients who start on clopidogrel, warfarin
or aspirin, adjusting for blood pressure lowering and lipid low-
ering drugs taken after the ﬁrst stroke, hypertension, heart
disease, diabetes, race, gender, age and residence (urban or not).
RESULTS: In total, there were 925 patients, 36% older than 60,
58% African Americans, and 35% males. Patients who persist
on the ﬁrst drug taken post-stroke (HR = 1.29, p = 0.03, CI
1.02–1.63), start on clopidogrel (HR = 1.42, p = 0.006 CI
1.10–1.82) or take up to two (HR = 1.43, p = 0.001, CI
1.15–1.78) blood pressure lowering drugs post-stroke are sig-
niﬁcantly more likely to have no recurrence. Patients with a diag-
nosis of heart disease (HR = 0.81, p = 0.05, CI 0.66–0.99),
hypertension (HR = 0.64, p = 0.00, CI 0.51–0.79) or diabetes
(HR = 0.75, p = 0.006, CI 0.61–0.92) post-stroke are less likely
to have no recurrence, i.e. to stay in remission after the ﬁrst
stroke. CONCLUSIONS: Among Medicaid patients, persistence
on the ﬁrst drug taken after a stroke reduces the likelihood of
recurrence. Clopidogrel and the combination of up to two blood
pressure lowering drugs are associated with a higher likelihood
of no recurrence. However, heart disease, hypertension and dia-
betes decrease the likelihood of avoiding a second stroke. These
results may inform care management plans for Medicaid
patients.
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OBJECTIVES: Disability presents a major economic and human-
istic burden among stroke survivors. To quantify disability in
patients, activities of daily living (ADLs) measures have been
used. The translation among measures, however, has not been
developed, leaving a signiﬁcant discontinuation of patient care
between facilities that use different measures. The purpose of 
this study is to develop a conversion system for two most widely
used ADL measures, the Motor component in Functional 
Independence Measure (M-FIM) and the Barthel Index (BI).
METHODS: We use Kansas City Stroke Study data. We stan-
dardized the scales of both instruments to 0–1 and rotated them
45 degrees in order to get a consistent conversion scheme regard-
less of the direction of the conversion (from BI to M-FIM or from
M-FIM to BI). We applied the censored heteroscedastic regres-
sion spline model using Monte Carlos Expectation and Condi-
tional Maximization (MCECM) algorithm, since the data is
censored in both boundaries (for M-FIM: 13–91, and BI: 0–100)
with ceiling and ﬂoor effects. RESULTS: Among 1676 records,
2.4% and 5.8% of M-FIM records, and 3.5% and 24% of BI
presented the lowest and highest scores respectively. Based on
our model, zero, 60, and 100 of BI scores are equivalent to 13
to 15, 59 to 62, and 88 to 91 of M-FIM. (Complete conversion
table will be provided in the presentation.) The two measures
were highly correlated (r = 0.9479, p < 0.0001), but the linear-
ity assumption was improper, particularly, for the higher score
range of the M-FIM and BI. CONCLUSIONS: For the contin-
uum of patient care, the conversion among scales is an impor-
tant issue. We developed a conversion scheme between two
widely used ADL measures, BI and M-FIM, based on their total
scores. Further research is planned to obtain a more robust and
precise conversion model addressing item level information.
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OBJECTIVES: We aimed to determine whether, and by how
much, stroke severity, as measured by the Modiﬁed Rankin Scale
(MRS) of disability, inﬂuences the duration of subsequent dis-
ability, and therefore the need for rehabilitation and nursing care.
METHODS: A total of 7599 patients were enrolled in a ran-
domised clinical trial (MATCH) of clopidogrel vs. aspirin +
clopidogrel after a transient ischaemic attack or ischaemic stroke
within 90 days (median 15 days). The two study arms were
pooled. The Modiﬁed Rankin Scale (MRS) was assessed at: base-
line (randomisation), months one, three, six, 12, 18 and follow-
ing a recurrent stroke. RESULTS: At baseline, 20.7% of 7599
patients were disabled (11.6% at MRS 3, 8.6% at MRS 4 and
0.5% at MRS 5). Median time to change from disabled state
(MRS 3, 4, or 5) to non-disabled state (MRS 0, 1, or 2) was
three-months for patients with moderate disability (MRS 3) and
18 months for patients with severe disability (MRS 4). For
patients with very severe disability (MRS 5), 80.7% remained
disabled at 18-months. Among the 804 patients who experienced
a recurrent ischaemic stroke during the study, 53.4% of patients
were disabled after the recurrent stroke (20.3% at MRS 3,
20.8% at MRS 4, and 12.3% for MRS 5). Median time to
change from disabled state to non-disabled state was six-months
for MRS 3 and more than 18-months for MRS 4. For MRS 5,
94.5% of patients still remained disabled. CONCLUSIONS:
More severe strokes and recurrent strokes cause longer-term dis-
ability. After a recurrent stroke, the median time to change from
a disabled to non-disabled state is six-months for patients with
moderate disability (MRS 3) and more than 18-months for
patients with severe disability (MRS 4). Almost all patients with
very severe disability (MRS 5), remain disabled and require per-
manent nursing care.
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OBJECTIVES: Percutaneous coronary intervention (PCI) using
a sirolimus-eluting stent (SES), coated with the immunosuppres-
sive agent sirolimus, dramatically reduces the risk of restenosis
compared to bare metal stent (BMS) implantation. However,
before SES can be widely adopted in clinical practice, it is essen-
tial to conduct an economic evaluation of this effective but
expensive device. Our study was undertaken to estimate the
three-year cumulative medical costs of stenting using SES com-
pared to BMS in the Japanese health care system. METHODS:
The data on clinical sequelae of stenting using BMS were derived
from our previous study, based on data collected from three
Japanese hospitals. We estimated that the probability of target-
lesion revascularization would be 0.15 times in SES implantation
compared to BMS implantation based on the recent meta-
analysis results (Babarille et al, 2004). The medical costs for pro-
cedures were obtained from published articles and were adjusted
to the January, 2005 level. Annual discount rate was set to 0.03.
Sensitivity analyses with different presumptions, including the
cost of intervention, the probability of target-lesion revascular-
